Cita APA

Stemler, J., & Carcas Sansuán, A. J. (2024). Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273: A randomized VACCELERATE trial in adults aged ≥75 years (EU-COVAT-1-AGED Part B).

Citación estilo Chicago

Stemler, Jannik, y Antonio Javier Carcas Sansuán. Immunogenicity, Reactogenicity, and Safety of a Second Booster With BNT162b2 or Full-dose MRNA-1273: A Randomized VACCELERATE Trial in Adults Aged ≥75 Years (EU-COVAT-1-AGED Part B). 2024.

Cita MLA

Stemler, Jannik, y Antonio Javier Carcas Sansuán. Immunogenicity, Reactogenicity, and Safety of a Second Booster With BNT162b2 or Full-dose MRNA-1273: A Randomized VACCELERATE Trial in Adults Aged ≥75 Years (EU-COVAT-1-AGED Part B). 2024.